Kronos Bio, Inc. KRON
0.88 0.00 (+0.00%)
At closeJun 20, 2025, 4:00 PM EDT
0.8701 Day range 0.881
52-week range unavailable
Analyst view
Price target (mean) 2.25
Ratings (0m) 2 1 buy · 1 hold · 0 sell
- Strong buy1
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 2.40M | +5.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 500.00K | -80.2% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 10.00M | +59.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 2.00M | -80.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 3, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 19, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Dec 19, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 27, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 21, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 17, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Nov 18, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 10, 2022 | Goldman Sachs | Maintained | — | Buy |
| Nov 9, 2022 | Piper Sandler | Maintained | — | Overweight |
| Sep 14, 2022 | Berenberg | Initiated | — | Buy |
| May 24, 2022 | Goldman Sachs | Maintained | — | Buy |
| May 23, 2022 | Piper Sandler | Maintained | — | Overweight |
| Feb 28, 2022 | Piper Sandler | Maintained | — | Overweight |
| Nov 10, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Jun 24, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Nov 3, 2020 | Cowen & Co. | Initiated | — | Outperform |
| Nov 3, 2020 | Goldman Sachs | Initiated | — | Buy |
| Nov 3, 2020 | Piper Sandler | Initiated | — | Overweight |
